MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'The Economic Times Healthcare and Biotech News' source. Tue, 16 Mar 2010 16:37:27 +0100 http://www.medworm.com/index.php?rid=3368511&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FJharkhand-govt-gives-NOC-to-SAIL-HEC-to-set-up-medical-colleges%2Farticleshow%2F5691388.cms The Jharkhand government has given a no-objection certificate to Heavy Engineering Corporation (HEC) and Steel Authority of India Limited (SAIL) to set up medical college in Ranchi and Bokaro respectively, in Jharkhand. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3368511 Tue, 16 Mar 2010 16:14:41 +0100 3368511 http://www.medworm.com/index.php?rid=3365104&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FSetback-for-Zydus-Cadila-in-trademark-case%2Farticleshow%2F5687061.cms In a setback to Ahmedabad-based drug-maker Zydus Cadila, the Supreme Court on Monday declined to interfere with a Madras High Court order which prevented the company from selling its anti-depressant drug Venz. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3365104 Mon, 15 Mar 2010 14:38:30 +0100 3365104 http://www.medworm.com/index.php?rid=3365101&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FRanbaxy-to-launch-anti-diabetic-drug-Actos-by-2012%2Farticleshow%2F5686004.cms Pharma major Ranbaxy Laboratories Friday said it will launch anti-diabetic drug Actos in the US by 2012. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3365101 Mon, 15 Mar 2010 10:29:00 +0100 3365101 http://www.medworm.com/index.php?rid=3365102&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FRanbaxy-settles-drug-dispute-with-Takeda-US-launch-in-2012%2Farticleshow%2F5685803.cms Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the patent litigation regarding diabetic drug Actos. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3365102 Mon, 15 Mar 2010 09:40:19 +0100 3365102 http://www.medworm.com/index.php?rid=3365103&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FElder-to-take-full-control-of-Bulgarian-arm%2Farticleshow%2F5683924.cms Mid-size drugmaker Elder Pharmaceuticals is increasing its stake in its Bulgarian subsidiary Elder Biomeda to 61% from the current 51% for around $12 million, people familiar with the matter said. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3365103 Sun, 14 Mar 2010 21:26:58 +0100 3365103 http://www.medworm.com/index.php?rid=3361281&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FFortis-to-widen-global-play%2Farticleshow%2F5678171.cms Fortis chairman Malvinder Singh is relocating to Singapore, as it plans to use the acquisition of hospital chain Parkway Holdings, as its vehicle for global expansion. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3361281 Fri, 12 Mar 2010 20:52:57 +0100 3361281 http://www.medworm.com/index.php?rid=3361280&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FSun-Pharmas-US-arm-launches-anticancer-injection%2Farticleshow%2F5677460.cms Sun Pharmaceutical's US arm Caraco has launched oxaliplatin injections, used in the treatment of cancer, in the American market. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3361280 Fri, 12 Mar 2010 16:12:30 +0100 3361280 http://www.medworm.com/index.php?rid=3356890&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FFortis-to-fund-Parkway-buy-via-loan-rights%2Farticleshow%2F5675728.cms Hospital chain Fortis Healthcare plans to fund its stake buy in Singapore's Parkway Holdings through a short-term loan and money raised through its recent rights issue, a top official said. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3356890 Fri, 12 Mar 2010 08:47:02 +0100 3356890 http://www.medworm.com/index.php?rid=3356891&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FDaiichi-eyes-Ranbaxy-for-expanding-in-Africa-Latin-America%2Farticleshow%2F5675711.cms "Daiichi Sankyo and Ranbaxy will collaborate in fast-growing emerging markets and fully deploy the hybrid business model," the company said. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3356891 Fri, 12 Mar 2010 08:42:06 +0100 3356891 http://www.medworm.com/index.php?rid=3356887&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FSun-Pharma-unit-Caraco-launches-anti-cancer-drug-in-US%2Farticleshow%2F5675374.cms Caraco Pharmaceutical Laboratories Ltd, a unit of Sun Pharmaceutical Industries Ltd, said late on Thursday it has launched the generic version of anti-cancer drug oxaliplatin in injection form in the US. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3356887 Fri, 12 Mar 2010 07:16:42 +0100 3356887 http://www.medworm.com/index.php?rid=3356888&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FPlanning-to-achieve-3-billion-turnover-by-2012-says-Ranbaxy%2Farticleshow%2F5674678.cms Indian drug maker Ranbaxy Laboratories Ltd said on Friday it was planning to achieve $3 billion in consolidated turnover by 2012 as part of its medium-term business plan. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3356888 Fri, 12 Mar 2010 04:54:02 +0100 3356888 http://www.medworm.com/index.php?rid=3356889&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FTorrent-inks-licensing-supply-agreement-with-AstraZeneca%2Farticleshow%2F5673678.cms Ahmedabad-based Torrent Pharmaceuticals, a part of Rs 6,100-crore Torrent Group, has struck a licensing and supply agreement with UK-based pharma MNC AstraZeneca. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3356889 Thu, 11 Mar 2010 19:38:09 +0100 3356889 http://www.medworm.com/index.php?rid=3352498&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FFortis-Healthcare-to-buy-239-stake-in-Singapores-Parkway-for-685-mn%2Farticleshow%2F5671913.cms Fortis will buy 23.9% of Singapore's Parkway. Fortis shares were up over 5%. Fortis hospital network will rise to 62. Top gainers, losers & recommendations (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3352498 Thu, 11 Mar 2010 10:51:54 +0100 3352498 http://www.medworm.com/index.php?rid=3348819&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FFortis-to-re-brand-10-Wockhardt-hospitals%2Farticleshow%2F5665339.cms Fortis Healthcare has decided to re-brand the 10 Wockhardt hospitals it acquired last year under the Fortis brandname from April 1. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3348819 Tue, 09 Mar 2010 21:04:25 +0100 3348819 http://www.medworm.com/index.php?rid=3348820&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FGSK-to-lower-prices-to-woo-India-mkt%2Farticleshow%2F5665174.cms GlaxoSmithKline CEO Andrew Witty says the pharma major plans to invest Rs 430 crore to develop vaccines here. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3348820 Tue, 09 Mar 2010 19:53:49 +0100 3348820 http://www.medworm.com/index.php?rid=3341015&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FDiagnostic-chains-scout-for-standalone-regional-buyouts%2Farticleshow%2F5655962.cms Diagnostic chains such as Dr Lal Pathlabs, Super Religare Laboratories, Piramal Diagnostics and Metropolis are scouting for regional diagnostic centres. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3341015 Sun, 07 Mar 2010 21:08:58 +0100 3341015 http://www.medworm.com/index.php?rid=3337164&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FStanding-guard-NPPA-asked-to-monitor-prices-of-antibiotics%2Farticleshow%2F5649003.cms The department of pharmaceuticals, or DoP, has asked the country’s drug price regulator to be on guard against a possible spike in antibiotic prices after a proposed anti-dumping duty on import of key ingredients takes effect. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3337164 Fri, 05 Mar 2010 19:28:00 +0100 3337164 http://www.medworm.com/index.php?rid=3329527&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FStrides-to-acquire-Aspens-Brazilian-facility-for-75-mn%2Farticleshow%2F5640002.cms Pharma firm Strides Arcolab today said it has entered into an agreement with South Africa-based Aspen to acquire the latters facility in Brazil for $75 million (nearly Rs 343 crore). (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3329527 Thu, 04 Mar 2010 06:14:04 +0100 3329527 http://www.medworm.com/index.php?rid=3329526&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FWockhardts-asset-sale-caught-in-creditors-crossfire%2Farticleshow%2F5638883.cms The sale of Wockhardt’s nutrition business to Abbott Laboratories has hit a roadblock as differences regarding rights on the sale proceeds have cropped up between the company’s secured and unsecured creditors. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3329526 Wed, 03 Mar 2010 19:30:10 +0100 3329526 http://www.medworm.com/index.php?rid=3325349&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FZydus-applies-for-Phase-II-III-H1N1-vaccine-trials%2Farticleshow%2F5637678.cms The race amongst Indian swine flu vaccine-makers seems to be moving to the next level with Cadila Healthcare Ltd, the Rs 2,900-crore Zydus Group's listed entity, filing for the next phase of clinical trials after completing the first phase. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3325349 Wed, 03 Mar 2010 13:06:48 +0100 3325349 http://www.medworm.com/index.php?rid=3325348&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FRanbaxy-loses-out-on-FDA-delay%2Farticleshow%2F5635398.cms Ranbaxy, the Indian unit of Japanese drugmaker Daiichi Sankyo, was to launch the generic version of the Japan-based Astellas’ Flomax on March 2 in the US, eight weeks before the drug’s patent expires in the US following an out-of-court settlement in 2007. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3325348 Tue, 02 Mar 2010 22:26:04 +0100 3325348 http://www.medworm.com/index.php?rid=3320456&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FGlenmark-unit-gets-US-nod-for-Parkinsons-drug%2Farticleshow%2F5632857.cms Glenmark Pharmaceuticals said its unit, Glenmark Generics Ltd, secured the US Food and Drug Administration approval to sell ropinirole hydrochloride tabltes in the United States. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3320456 Tue, 02 Mar 2010 08:21:09 +0100 3320456 http://www.medworm.com/index.php?rid=3320455&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FSC-rejects-Bayers-plea-to-stay-Ciplas-cancer-clone%2Farticleshow%2F5631323.cms The Supreme Court turned down a request by German drugmaker Bayer AG to stop Mumbai-based Cipla from launching the low-cost version of Bayer’s patented cancer medicine Nexavar while admitting the case. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3320455 Mon, 01 Mar 2010 18:48:20 +0100 3320455 http://www.medworm.com/index.php?rid=3317440&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FNo-interim-stay-on-Ciplas-Nexavar-clone%2Farticleshow%2F5629456.cms The Supreme Court turned down a request by German drugmaker Bayer AG to stop Mumbai-based Cipla from launching the low-cost version of Bayer’s patented cancer medicine Nexavar while admitting the case. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3317440 Sun, 28 Feb 2010 19:45:20 +0100 3317440 http://www.medworm.com/index.php?rid=3317439&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FSecured-lenders-insecure-over-Wockhardts-plan%2Farticleshow%2F5629451.cms Secured and unsecured creditors of debt-ridden pharma firm Wockhardt are singing in different tunes to support the sale of the company’s nutrition business to Abbott Laboratories. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3317439 Sun, 28 Feb 2010 19:42:48 +0100 3317439 http://www.medworm.com/index.php?rid=3313502&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FUnion-Budget-2010-Pharma-industry-welcomes-tax-incentives-for-RD%2Farticleshow%2F5621373.cms Finance minister proposed a weighted tax deduction on expenditure incurred in in-house research and development activities to 200 per cent from the current 150 per cent in the Budget. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3313502 Fri, 26 Feb 2010 15:21:59 +0100 3313502 http://www.medworm.com/index.php?rid=3309649&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FUnion-Budget-2010-Private-hospitals-likely-to-benefit%2Farticleshow%2F5620315.cms Private hospitals and medical equipment makers expect to benefit from the government’s plan to increase public healthcare expenditure even as their long standing demand to give healthcare an infrastructure status has once again been ignored. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3309649 Fri, 26 Feb 2010 11:22:24 +0100 3309649 http://www.medworm.com/index.php?rid=3309650&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FUnion-Budget-2010-Drugmakers-to-benefit-from-budgetary-measures%2Farticleshow%2F5620158.cms Indian drugmakers and research establishments will benefit from the increase in weighted deduction on in-house research and development (R&D) expenses to 200% from the present 150%, as proposed in the union budget. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3309650 Fri, 26 Feb 2010 10:51:31 +0100 3309650 http://www.medworm.com/index.php?rid=3309648&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FDaiichi-Ranbaxy-synergy-plan-delayed-announcement-by-Mar%2Farticleshow%2F5616715.cms Ranbaxy Laboratories and its Japanese parent Daiichi Sankyo's proposal to unveil a three-year plan for exploiting synergies in operations to enhance their generic and branded business worldwide has been delayed by two months. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3309648 Thu, 25 Feb 2010 16:07:24 +0100 3309648 http://www.medworm.com/index.php?rid=3300406&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FPolymed-gets-to-sell-IV-device-in-Germany%2Farticleshow%2F5609543.cms IN a setback for global medical devicemaker B Braun, a local German court has overturned an interim injunction order allowing Indian company Polymed to start selling its Safety IV Cannula in that country. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3300406 Tue, 23 Feb 2010 20:20:19 +0100 3300406 http://www.medworm.com/index.php?rid=3300405&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FGlaxos-plan-to-acquire-5-stake-in-Dr-Reddys-may-fizzle-out%2Farticleshow%2F5609345.cms UK-BASED GlaxoSmithKline’s (GSK) plan to buy about 5% stake in Dr Reddy’s Laboratories (DRL) for $150-160 million is stuck and unlikely to happen, two people familiar with the matter said. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3300405 Tue, 23 Feb 2010 19:18:42 +0100 3300405 http://www.medworm.com/index.php?rid=3293274&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FCRAM-sector-has-been-growing-at-15-20-Jubilant-Organosys%2Farticleshow%2F5602842.cms Hari Bhartia, co-chairman & managing director, Jubilant Organosys, in a chat with ET Now talks about the CRAM sector. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3293274 Mon, 22 Feb 2010 07:45:36 +0100 3293274 http://www.medworm.com/index.php?rid=3293271&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FWe-hope-that-stimulus-is-not-withdrawn-Jubilant-Organosys%2Farticleshow%2F5602773.cms Hari Bhartia, co-chairman & managing director, Jubilant Organosys, in achat with ET Now, talks about pharma sector’s expectations from the Budget. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3293271 Mon, 22 Feb 2010 07:26:33 +0100 3293271 http://www.medworm.com/index.php?rid=3293273&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FUmbilical-cord-banking-catching-up-in-metros-%2Farticleshow%2F5601472.cms Banking umbilical cord blood as an investment to generate stem cells in future for treatment of possible lifethreatening diseases is catching up across the country, though mostly in urban centres. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3293273 Mon, 22 Feb 2010 00:24:46 +0100 3293273 http://www.medworm.com/index.php?rid=3293272&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FPrices-of-antibiotics-may-flare-up-50%2Farticleshow%2F5601219.cms A government proposal to slap anti-dumping duties on Chinese and Mexican imports of two key pharma ingredients will push up the prices of common antibiotics like Mox, Augmentin and Sporidex by almost 50%, say their makers. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3293272 Sun, 21 Feb 2010 20:16:33 +0100 3293272 http://www.medworm.com/index.php?rid=3291665&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FHNIs-see-net-worth-in-stem-cells%2Farticleshow%2F5600207.cms Banking umbilical cord blood as an investment to generate stem cells in future for treatment of possible life-threatening diseases is catching up across the country, though mostly in urban centers. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3291665 Sun, 21 Feb 2010 13:43:32 +0100 3291665 http://www.medworm.com/index.php?rid=3291666&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FGuardian-Lifecare-to-invest-Rs-100cr-to-double-retail-presence%2Farticleshow%2F5598861.cms Medicine retail chain Guardian Lifecare on Sunday said it will double the number of its stores to 400 over the next two years with an investment of Rs 100 crore. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3291666 Sun, 21 Feb 2010 05:43:45 +0100 3291666 http://www.medworm.com/index.php?rid=3289808&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FBritish-PM-to-present-Amitabh-to-Bachchan%2Farticleshow%2F5594719.cms Gordon Brown will present 'Amitabh', a module diabetes unit-bus to be based in Mumbai, to Amitabh Bachchan. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3289808 Fri, 19 Feb 2010 20:47:31 +0100 3289808 http://www.medworm.com/index.php?rid=3289809&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FSun-Pharmas-cancer-drug-application-gets-EMA-backing%2Farticleshow%2F5593957.cms India's Sun Pharmaceutical on Friday received recommendations from the European Medicines Agency for granting it marketing authorisation in the continent for cancer drug Doceferez. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3289809 Fri, 19 Feb 2010 16:59:49 +0100 3289809 http://www.medworm.com/index.php?rid=3286106&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FTaro-to-shut-down-Irish-plant-to-control-losses%2Farticleshow%2F5590627.cms Israeli drugmaker Taro Pharma on Thursday said it is closing its Irish manufacturing plant to stem further losses, inviting allegations of misleading investors and employees from India’s Sun pharma with whom it is engaged in a bitter takeover battle. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3286106 Thu, 18 Feb 2010 23:57:04 +0100 3286106 http://www.medworm.com/index.php?rid=3286102&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FSwiss-loan-puts-Wockhardt-in-a-spot-of-bother%2Farticleshow%2F5590390.cms The company’s debt-laden Swiss subsidiary is trying hard to strike a deal with offshore lenders even as the parent Wockhardt is involved in a complex legal tussle with foreign unsecured creditors in the Bombay High Court. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3286102 Thu, 18 Feb 2010 20:46:43 +0100 3286102 http://www.medworm.com/index.php?rid=3286105&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FMCI-issues-new-ethics-code-for-doctors%2Farticleshow%2F5590118.cms The Medical Council of India (MCI) has finalised a code of conduct restraining doctors from getting influenced by drug makers through gifts and other disguised bribes to bring down costs for patients. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3286105 Thu, 18 Feb 2010 19:30:25 +0100 3286105 http://www.medworm.com/index.php?rid=3286103&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FBiogen-to-bring-its-global-drug-portfolio-to-India%2Farticleshow%2F5589945.cms US-based Biogen Idec plans to roll out its entire range of medicines in the fast-growing, Rs 40,000-crore Indian retail drug market over the next few years through its wholly-owned Indian arm. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3286103 Thu, 18 Feb 2010 18:44:45 +0100 3286103 http://www.medworm.com/index.php?rid=3286104&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FDishman-ties-up-with-California-biotech-co%2Farticleshow%2F5589924.cms The Rs 1,000-crore Dishman Pharmaceuticals, an Ahmedabad-based contract research and manufacturing services (CRAMS) major, has entered into a strategic alliance with a California-based biotech company Codexis. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3286104 Thu, 18 Feb 2010 18:41:01 +0100 3286104 http://www.medworm.com/index.php?rid=3281839&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FDishman-in-pact-with-US-based-Codexis%2Farticleshow%2F5587412.cms The Rs 1000-crore Dishman Pharmaceuticals, an Ahmedabad-based Contract Research and Manufacturing Services (CRAMS) major, has entered into a strategic alliance with a California-based biotech company — Codexis Inc. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3281839 Thu, 18 Feb 2010 07:01:39 +0100 3281839 http://www.medworm.com/index.php?rid=3281838&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FGlenmark-Bright-future-in-the-UK-and-beyond%2Farticleshow%2F5585839.cms With its global headquarters in Mumbai, pharmaceutical group Glenmark does business in over 60 countries around the world. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3281838 Wed, 17 Feb 2010 20:02:19 +0100 3281838 http://www.medworm.com/index.php?rid=3278213&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FAbbott-makes-open-offer-for-20-pc-in-Solvay-Pharma-India%2Farticleshow%2F5583875.cms US-based pharmaceutical firm Abbott Laboratories announced completing the acquisition of the global drug business of Solvay SA, consequent to which it has made an offer to acquire 20 per cent of Solvay's India business. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3278213 Wed, 17 Feb 2010 09:46:23 +0100 3278213 http://www.medworm.com/index.php?rid=3268611&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FHinduja-Ventures-to-acquire-IDL-Speciality-Chemicals%2Farticleshow%2F5569649.cms Hinduja Ventures on Saturday said its board has approved the acquisition of pharma firm IDL Speciality Chemicals and also decided to enter into an MoU to that effect. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3268611 Sat, 13 Feb 2010 13:27:37 +0100 3268611 http://www.medworm.com/index.php?rid=3261161&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FRanbaxy-to-market-Daiichis-products-in-Mexico%2Farticleshow%2F5558425.cms Daiichi Sankyo said its Indian arm Ranbaxy Laboratories will start selling its original products in Mexico as part of its strategy to leverage Ranbaxy’s global marketing presence. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3261161 Wed, 10 Feb 2010 21:22:29 +0100 3261161 http://www.medworm.com/index.php?rid=3257086&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FHC-rejects-Bayer-plea-on-Nexavar-copycat%2Farticleshow%2F5554114.cms The Delhi HC dismissed an appeal by German drugmaker Bayer that sought to stop Cipla from obtaining a marketing approval from the country’s drug regulator to launch a low-cost version of patented cancer drug Nexavar in India. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3257086 Tue, 09 Feb 2010 20:46:35 +0100 3257086 http://www.medworm.com/index.php?rid=3249642&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FBirla-Kerala-Vaidyashala-to-tie-up-with-pharma-cos-for-distbution%2Farticleshow%2F5548313.cms Birla Kerala Vaidyashala to tie-up with local pharma companies to sell its range of products across the country. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3249642 Mon, 08 Feb 2010 09:41:27 +0100 3249642 http://www.medworm.com/index.php?rid=3245826&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FGovt-plans-Rs-2000-crore-fund-for-pharma-research%2Farticleshow%2F5543292.cms In an ambitious move to boost drug discovery, the Centre plans to create a fund of Rs 2,000-3,000 crore for pharma research and development, a top government official said here today. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3245826 Sat, 06 Feb 2010 14:59:33 +0100 3245826 http://www.medworm.com/index.php?rid=3245824&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FRDPL-inks-pacts-with-Rajasthan-govt-for-generic-drug-stores%2Farticleshow%2F5542482.cms State owned drug manufacturer Rajasthan Drugs and Pharmaceuticals Limited has joined hands with Rajasthan medical department and cooperative department to roll out 105 generic medicine stores across the state within one month. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3245824 Sat, 06 Feb 2010 09:30:50 +0100 3245824 http://www.medworm.com/index.php?rid=3245825&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FAllow-arms-to-pledge-assets-Wockhardt%2Farticleshow%2F5540541.cms Troubled pharma firm Wockhardt on Friday argued before the Bombay High Court that none of its subsidiaries should face any restrictions in pledging their assets to borrow. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3245825 Fri, 05 Feb 2010 18:41:44 +0100 3245825 http://www.medworm.com/index.php?rid=3242019&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FUnhappy-FDA-tells-Ranbaxy-to-review-units%2Farticleshow%2F5536662.cms The US drugs regulator has asked Indian pharma company Ranbaxy to immediately assess the manufacturing practices at its plants that make drugs for the American market. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3242019 Thu, 04 Feb 2010 21:15:31 +0100 3242019 http://www.medworm.com/index.php?rid=3242016&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FSun-barred-from-Taro-warrant-conversion%2Farticleshow%2F5536502.cms Sun Pharma’s near two-year legal battle with Taro board to get control of the drugmaker is set to drag on, as the Israeli Supreme Court has directed the Indian company not to convert its warrants into shares which would have raised its stake to 41%, from the current 36%. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3242016 Thu, 04 Feb 2010 19:05:52 +0100 3242016 http://www.medworm.com/index.php?rid=3242017&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FWockhardts-foreign-lenders-allow-firms-nutritional-business-sale%2Farticleshow%2F5536281.cms The foreign lenders of pharmaceutical major Wockhardt on Thursday said they would not object to proposed sale of its nutritional business to Abbott. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3242017 Thu, 04 Feb 2010 16:44:11 +0100 3242017 http://www.medworm.com/index.php?rid=3242018&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FWockhardt-view-sought-on-keeping-sale-proceeds%2Farticleshow%2F5536465.cms The Bombay High Court on Thursday asked Wockhardt and its promoters to clarify if they will deposit proceeds from sale of the nutrition business in an escrow account, if court allows it to complete the transaction with Abbott. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3242018 Thu, 04 Feb 2010 06:30:53 +0100 3242018 http://www.medworm.com/index.php?rid=3233992&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FDrug-formulations-pep-up-sector-but-contract-research-spoils-Q3-party%2Farticleshow%2F5529476.cms However, pharma companies mainly into formulations have managed to show strong growth, except for those who had operations in Germany and suffered losses due to regulatory changes for drug procurement. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3233992 Tue, 02 Feb 2010 21:07:32 +0100 3233992 http://www.medworm.com/index.php?rid=3229849&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FNo-assets-sale-while-cases-on-Wockhardt%2Farticleshow%2F5525784.cms Troubled pharmaceutical company Wockhardt has told its foreign lenders that it will not sell any assets as long as winding-up petitions filed by them are being heard by the Bombay High Court. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3229849 Mon, 01 Feb 2010 19:27:21 +0100 3229849 http://www.medworm.com/index.php?rid=3226280&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FInfosys-to-partner-with-Elan-Pharmaceuticals%2Farticleshow%2F5523852.cms Infosys Technologies Limited would design and implement the Research Informatics System at Elan Pharmaceuticals, Inc, a leading biotechnology company, to accelerate discovery research using a co-creation engagement model that leverages Infosys' existing intellectual property in this field. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3226280 Mon, 01 Feb 2010 09:54:44 +0100 3226280 http://www.medworm.com/index.php?rid=3226278&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FPharma-biggies-disclose-payments-made-to-doctors%2Farticleshow%2F5522987.cms Pharma biggies worldwide have started disclosing payments made to physicians, including dollars spent on consulting gigs, clinical trials and even meals. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3226278 Mon, 01 Feb 2010 05:28:08 +0100 3226278 http://www.medworm.com/index.php?rid=3226279&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FSun-gets-a-boost-as-FDA-rejects-rival-Osmoticas-plea%2Farticleshow%2F5521731.cms Sun Pharmaceutical Industries’ plan to launch a copy of US-based Wyeth’s blockbuster anti-depressant capsule Effexor XR got a big boost after the US drug regulator rejected rival Osmotica Pharmaceuticals’s appeal to bar the Indian company, said a top executive, reports Khomba Singh. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3226279 Sun, 31 Jan 2010 19:18:06 +0100 3226279 http://www.medworm.com/index.php?rid=3222208&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FWockhardt-told-to-clarify-asset-sale-plan-to-lenders%2Farticleshow%2F5515260.cms The Bombay High Court asked Wockhardt to clarify with its foreign lenders which assets the troubled pharma firm could sell during the pendency of the winding-up petitions. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3222208 Fri, 29 Jan 2010 20:24:53 +0100 3222208 http://www.medworm.com/index.php?rid=3218788&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FDishman-to-chase-high-potency-therapies%2Farticleshow%2F5510837.cms Dishman Pharmaceuticals Ltd, will now focus on the high-potency therapies like steroids, hormones, isotopes and cytotoxics. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3218788 Thu, 28 Jan 2010 17:32:04 +0100 3218788 http://www.medworm.com/index.php?rid=3214795&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FIndia-asks-Kenya-to-change-law-making-generics-illegal-%2Farticleshow%2F5507375.cms The Kenyan legislation lays down that all generics will be treated as counterfeits and rejected in case a patent holder in a third country files a dispute. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3214795 Thu, 28 Jan 2010 00:08:39 +0100 3214795 http://www.medworm.com/index.php?rid=3214796&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FTorrent-Pharma-Q3-sales-up-by-635%2Farticleshow%2F5506450.cms Torrent Pharmaceuticals Ltd reported a 63.5 per cent jump in consolidated net profit at Rs 82.9 crore for the quarter ending December 31, 2009. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3214796 Wed, 27 Jan 2010 17:08:43 +0100 3214796 http://www.medworm.com/index.php?rid=3210496&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FBiocons-Clingene-SIRO-Clinpharm-in-alliance-talks%2Farticleshow%2F5502878.cms Biocon's clinical services arm Clingene is actively exploring an alliance with Mumbai-based clinical research organisation SIRO Clinpharm. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3210496 Tue, 26 Jan 2010 20:17:07 +0100 3210496 http://www.medworm.com/index.php?rid=3206995&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FPharma-cos-to-hike-insulin-prices-by-up-to-15%2Farticleshow%2F5501050.cms Drug price regulator National Pharmaceutical Pricing Authority allows cos to up MRP of popular insulin brands by 15%. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3206995 Tue, 26 Jan 2010 00:47:20 +0100 3206995 http://www.medworm.com/index.php?rid=3206994&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FWockhardt-CDR-plan-may-set-precedent-for-debt-recovery-%2Farticleshow%2F5501037.cms Troubled pharma company Wockhardt’s corporate debt restructuring (CDR) plans that led to its overseas unsecured creditors taking the company to court could set a legal precedent for the recovery of such debt. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3206994 Tue, 26 Jan 2010 00:35:18 +0100 3206994 http://www.medworm.com/index.php?rid=3203086&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FTrivitron-commissions-South-Asias-first-medical-tech-park-near-Chennai%2Farticleshow%2F5499699.cms South Asia’s first medical technology park was commissioned on Monday at Irungattukottai, near Chennai by TN Deputy CM MK Stalin. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3203086 Mon, 25 Jan 2010 14:59:19 +0100 3203086 http://www.medworm.com/index.php?rid=3203087&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FWockhardt-sells-18-acres-in-city-to-Runwal-for-Rs-200-cr%2Farticleshow%2F5496330.cms The Khorakiwala family, promoters of the troubled pharma company Wockhardt, has sold nearly 18 acre of land at Mulund for Rs 200 crore to a city-based developer, Runwal Group, and a real estate fund. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3203087 Sun, 24 Jan 2010 19:48:24 +0100 3203087 http://www.medworm.com/index.php?rid=3201467&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FApollo-to-manage-Indira-Gandhi-hospital-in-Maldives%2Farticleshow%2F5493005.cms Corporate healthcare major Apollo Hospitals has entered into an agreement with the Republic of Maldives to manage the 280-bed Indira Gandhi Memorial Hospital (IGMH) in Male. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3201467 Sat, 23 Jan 2010 15:50:39 +0100 3201467 http://www.medworm.com/index.php?rid=3199506&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FBiocon-LTD-signs-MoU-with-Malaysian-based-BiotechCorp-%2Farticleshow%2F5489564.cms Biocon Limited today signed an MoU with Malaysia's Biotechnology Corporation (BiotechCorp) to explore collaboration and potential investment in Malaysia's biotechnology industry. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3199506 Fri, 22 Jan 2010 15:42:03 +0100 3199506 http://www.medworm.com/index.php?rid=3199507&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FFortis-aims-to-be-a-billion-dollar-company-in-3-4-years-%2Farticleshow%2F5489539.cms Hospital chain Fortis Healthcare today said it aims to become a billion dollar company in the next three to four years on the back on ongoing expansions. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3199507 Fri, 22 Jan 2010 15:34:48 +0100 3199507 http://www.medworm.com/index.php?rid=3196040&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FJubilant-to-hive-off-non-core-business%2Farticleshow%2F5486377.cms Pharmaceutical company Jubilant Organosys is demerging its non-core business - agri and performance polymer - into a separate subsidiary to focus on its pharma business. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3196040 Thu, 21 Jan 2010 21:23:15 +0100 3196040 http://www.medworm.com/index.php?rid=3191644&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FLupin-plants-get-USFDA-nod-co-to-sell-new-products%2Farticleshow%2F5482537.cms Drug maker Lupin has received clearance from the US drug regulator for its plant at Mandideep in Madhya Pradesh, allowing the Mumbai-based company to start selling new products made at the plant to the world’s largest drug market. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3191644 Wed, 20 Jan 2010 20:32:36 +0100 3191644 http://www.medworm.com/index.php?rid=3187599&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FLupin-cant-sell-pill-in-US-Teva-files-patent-suit%2Farticleshow%2F5478754.cms Israeli drugmaker Teva Pharma has filed a patent infringement suit in the US against Lupin that prevents the Indian pharma company from selling the generic, or copycat, version of Teva’s birth control drug, LoSeasonique, for 30 months in a key market. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3187599 Tue, 19 Jan 2010 22:15:09 +0100 3187599 http://www.medworm.com/index.php?rid=3177806&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FWockhardt-wont-sell-assets-without-notice%2Farticleshow%2F5450490.cms Debt-ridden pharma firm Wockhardt has assured foreign creditors such as Calyon, Barclays, and a trust, representing the foreign currency convertible bondholders. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3177806 Fri, 15 Jan 2010 19:43:51 +0100 3177806 http://www.medworm.com/index.php?rid=3169674&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FBaring-lines-up-150-mn-for-pharma-play%2Farticleshow%2F5442041.cms Baring Private Equity Partners is in discussions with a few mid-sized privately held pharma companies which could see the PE firm investing up to $150 million (over Rs 675 crore) in the next few months, a Baring executive said. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3169674 Wed, 13 Jan 2010 18:57:00 +0100 3169674 http://www.medworm.com/index.php?rid=3165743&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FWockhardt-gets-US-FDA-tentative-nod-for-Levofloxacin-tablets%2Farticleshow%2F5441212.cms Pharma major Wockhardt on Wednesday said it has received tentative approval from the US drug regulator to market Levofloxacin tablets, used for treatment in a broad spectrum of bacterial infections. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3165743 Wed, 13 Jan 2010 12:24:52 +0100 3165743 http://www.medworm.com/index.php?rid=3165742&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FUnder-fire-WHO-ready-to-review-handling-of-flu-pandemic%2Farticleshow%2F5440466.cms The World Health Organisation said on Tuesday that it was ready to hold an independent review of its response to swine flu, amid growing criticism of official handling of the pandemic. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3165742 Wed, 13 Jan 2010 08:26:57 +0100 3165742 http://www.medworm.com/index.php?rid=3165740&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FDishman-Pharma-to-set-up-4-API-plants%2Farticleshow%2F5439934.cms Dishman Pharmaceuticals and Chemicals Ltd is planning to set up four active pharmaceutical ingredient plants. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3165740 Wed, 13 Jan 2010 06:16:54 +0100 3165740 http://www.medworm.com/index.php?rid=3165741&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FWockhardt-lenders-offer-to-trade-bonds-for-26-stake%2Farticleshow%2F5438587.cms Foreign lenders led by US hedge fund QVT - that own overseas bonds worth $66 million in Wockhardt - have proposed a plan that would give them about 26% stake in the troubled pharmaceutical company. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3165741 Tue, 12 Jan 2010 19:23:32 +0100 3165741 http://www.medworm.com/index.php?rid=3162167&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FDishman-Pharmaceuticals-to-raise-Rs-75-cr%2Farticleshow%2F5437786.cms Dishman Pharmaceuticals and Chemicals on Tuesday said it will raise Rs 75 crore by issuing debentures for meeting regular capital expenditure. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3162167 Tue, 12 Jan 2010 13:01:53 +0100 3162167 http://www.medworm.com/index.php?rid=3162165&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FSun-threatens-to-sue-Taro-directors%2Farticleshow%2F5435663.cms Sun Pharma on Monday threatened to take legal against the directors of the Israeli drug firm Taro, which is fighting a takeover battle with the domestic firm, for acting against the interest of its shareholders. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3162165 Tue, 12 Jan 2010 05:27:02 +0100 3162165 http://www.medworm.com/index.php?rid=3162166&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FSun-Pharma-asks-Taro-board-to-stop-supporting-Levitt%2Farticleshow%2F5435121.cms Sun Pharma has written to the board of Taro to stop supporting the Levitt family who has been opposing the acquisition of the company by the Indian company. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3162166 Tue, 12 Jan 2010 01:12:06 +0100 3162166 http://www.medworm.com/index.php?rid=3158862&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FGovt-to-build-special-zones-for-pharma-at-intl-terminals-Azad%2Farticleshow%2F5434154.cms The government is planning to create special zones for pharma products at international cargo terminals, Union Health Minister Ghulam Nabi Azad said in Mumbai on Monday. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3158862 Mon, 11 Jan 2010 15:10:36 +0100 3158862 http://www.medworm.com/index.php?rid=3158859&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FSun-Pharma-threatens-to-sue-Taro-directors%2Farticleshow%2F5434080.cms Sun Pharma on Monday threatened to take legal against the directors of the Israeli drug firm Taro, which is fighting a takeover battle with the domestic firm, for acting against the interest of its shareholders. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3158859 Mon, 11 Jan 2010 14:41:31 +0100 3158859 http://www.medworm.com/index.php?rid=3158860&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FJapan-may-open-up-to-Indian-generics-%2Farticleshow%2F5431796.cms Japan has veered round to considering India’s demand to open up its over $100-billion pharmaceutical market to Indian generic, or off-patent , drug producers after four years of dogged resistance, a govt official said. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3158860 Sun, 10 Jan 2010 23:24:15 +0100 3158860 http://www.medworm.com/index.php?rid=3158861&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FNatco-to-launch-cancer-drug-as-min-stays-DCGI-order%2Farticleshow%2F5431729.cms The original maker of the drug, American firm Abraxis Bioscience had complained about the side effects of Natco’s version of the medicine. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3158861 Sun, 10 Jan 2010 22:39:49 +0100 3158861 http://www.medworm.com/index.php?rid=3157143&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FQVT-considers-filing-winding-up-petitions-against-Wockhardt%2Farticleshow%2F5430633.cms US-based investor fund QVT Advisers is understood to be considering filing winding up petitions in the US, the UK and other countries against the Wockhardt group. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3157143 Sun, 10 Jan 2010 10:05:21 +0100 3157143 http://www.medworm.com/index.php?rid=3155114&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2FNews%2FNews-By-Industry%2FHealthcare%2FBiotech%2FDubais-Moopen-Group-to-invest-200-mn-in-Indian-healthcare%2Farticleshow%2F5427953.cms Gulf-based healthcare tycoon Azad Moopen is investing over Rs 10 billion ($200 million) for setting up hospitals and eye-care centres across India, including his home state of Kerala. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3155114 Sat, 09 Jan 2010 09:44:29 +0100 3155114 http://www.medworm.com/index.php?rid=3157142&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FIndia-would-see-massive-boost-in-drug-manufacturing-sector%2Farticleshow%2F5427928.cms With the country's capacity to manufacture medicines at competitive prices, there is a big opportunity for investment in the drug manufacturing sector, Health Minister Ghulam Nabi Azad said. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3157142 Sat, 09 Jan 2010 09:38:21 +0100 3157142 http://www.medworm.com/index.php?rid=3155110&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Farticleshow%2F5424142.cms KeraSoft Eyecare, the Indian arm of UK-based UltraVision, has tied up with the Chaithanya Eye Hospital and Research Institute in Thiruvananthapuram, targeting the domestic market for treating eye disorders. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3155110 Fri, 08 Jan 2010 11:09:47 +0100 3155110 http://www.medworm.com/index.php?rid=3155111&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Farticleshow%2F5423358.cms The hospitality map of Chennai is witnessing a paradigm shift with action shifting from the arterial Mount Road and the airport to upcoming corridors like MRC Nagar and Guindy. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3155111 Fri, 08 Jan 2010 07:11:24 +0100 3155111 http://www.medworm.com/index.php?rid=3155112&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Farticleshow%2F5421983.cms Strides Acrolabs is discussing drug supply deal for niche therapeutics areas with global drug pharma companies. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3155112 Thu, 07 Jan 2010 20:48:46 +0100 3155112 http://www.medworm.com/index.php?rid=3155113&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Farticleshow%2F5421135.cms Biotechnology firm Transgene Biotek said on Thursday it has signed a pact with Dr Reddy's Lab to manufacture a drug named, Orlistat used in treating obesity. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3155113 Thu, 07 Jan 2010 15:55:49 +0100 3155113 http://www.medworm.com/index.php?rid=3151269&cid=s_38573_34_f&fid=38573&url=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Fnews-by-industry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2FRanbaxy-in-talks-to-acquire-Bangalore-vaccine-co-for-Rs-50-cr%2Farticleshow%2F5418148.cms Ranbaxy Laboratories has started discussions to buy a privately-held Bangalore-based vaccine company, two persons familiar with the development said. (Source: The Economic Times Healthcare and Biotech News) The Economic Times Healthcare and Biotech News news http://www.medworm.com/rss/comments.php?id=3151269 Wed, 06 Jan 2010 19:48:16 +0100 3151269